Valsartan (VST) is a poorly soluble antihypertensive drug characterized by its limited
dissolution rate and low bioavailability. This study aims to improve VST solubility and …

The present studies entail formulation development of novel solid self-nanoemulsifying drug
delivery systems (S-SNEDDS) of valsartan with improved oral bioavailability, and evaluation …

Valsartan, an angiotensin II receptor antagonist, is widely used to treat high blood pressure
in the clinical setting. However, its poor water solubility results in the low oral bioavailability …

The aim of this work was to develop self-nanoemulsifying liquisolid tablets (SNELT) to
enhance the dissolution profile of poorly water-soluble simvastatin. SNELT present a unique …

The purpose of this study is to improve the dissolution and oral bioavailability of an oily drug,
vitamin K1 (VK1) by combination of self-nanoemulsifying and liquisolid technologies. The …

The main objective this study is to prepare and evaluate the selfnanoemulsifying drug
delivery (SNEDDS) system in order to achieve a better dissolution rate of a poorly water …

The aim of the present study was to develop a novel semi-solid self-microemulsifying drug
delivery system (SMEDDS) using Gelucire® 44/14 as oil with strong solid character to …

The current studies entail development and evaluation of solid self-nanoemulsifying drug
delivery systems (S-SNEDDS) employing porous carriers for enhancing the oral …

The present study is aim to prepare and evaluate the selfnanoemulsifying drug delivery
(SNEDDS) system of a poorly water soluble drug valsartan in order to achieve a better …

To improve the dissolution and oral absorption of poorly water soluble drug-telmisartan, a
self-nanoemulsifying system (SNES) was developed, characterized, and its relative …